BioCentury
ARTICLE | Politics & Policy

NICE still mulling changes

September 18, 2014 1:14 AM UTC

The U.K.'s NICE said it is undecided on how to amend its medicine and technology appraisal methods. Moreover, NICE said any changes to its appraisal methods will not sufficiently address concerns about how the NHS accesses new treatments.

To help address such concerns, NICE proposed creating an innovation office within NICE that would work with development-stage companies. NICE also said there needs to be agreement among NICE, NHS and the Department of Health concerning NHS's "willingness to pay for new treatments." ...